In breast cancer, MSCs secrete VEGF, SDF-1, and CCL5 [94], which enhance breast cancer cell mobility and invasiveness [95] and induce EMT in primary tumor cells, which aids in metastasis to secondary locations [96]. Here, CCL5 is linked to breast cancer.